Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis
Arthritis Care & Research · 2024
DOI: 10.1002/acr.25354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Care & Research, 2024. Verfasst von Shuang Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Endopeptidases, Serine Endopeptidases, Gelatinases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stichting De Cock-Hadders, China Scholarship Council.
Abstract (Originalsprache)
Objective
Giant cell arteritis (GCA) is characterized by granulomatous inflammation of the medium‐ and large‐sized arteries accompanied by remodeling of the vessel wall. Fibroblast activation protein alpha (FAP) is a serine protease that promotes both inflammation and fibrosis. Here, we investigated the plasma levels and vascular expression of FAP in GCA.
Methods
Plasma FAP levels were measured with enzyme‐linked immunosorbent assay in treatment‐naive patients with GCA (n = 60) and polymyalgia rheumatica (PMR) (n = 63) compared with age‐ and sex‐matched healthy controls (HCs) (n = 42) and during follow‐up, including treatment‐free remission (TFR). Inflamed temporal artery biopsies (TABs) of patients with GCA (n = 9), noninflamed TABs (n = 14), and aorta samples from GCA‐related (n = 9) and atherosclerosis‐related aneurysm (n = 11) were stained for FAP using immunohistochemistry. Immunofluorescence staining was performed for fibroblasts (CD90), macrophages (CD68/CD206/folate receptor beta), vascular smooth muscle cells (desmin), myofibroblasts (α‐smooth muscle actin), interleukin‐6 (IL‐6), and matrix metalloproteinase‐9 (MMP‐9).
Results
Baseline plasma FAP levels were significantly lower in patients with GCA compared with patients with PMR and HCs and inversely correlated with systemic markers of inflammation and angiogenesis. FAP levels decreased even further at 3 months on remission in patients with GCA and gradually increased to the level of HCs in TFR. FAP expression was increased in inflamed TABs and aorta of patients with GCA compared with control tissues. FAP was abundantly expressed in fibroblasts and macrophages. Some of the FAP + fibroblasts expressed IL‐6 and MMP‐9.
Conclusion
FAP expression in GCA is clearly modulated both in plasma and in vessels. FAP may be involved in the inflammatory and remodeling processes in GCA and have utility as a target for imaging and therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
ORCID-Profile: Shuang Xu, William F Jiemy, Yannick van Sleen, Kornelis S M van der Geest, Peter Heeringa, Maria Sandovici
Förderung
- Stichting De Cock-Hadders
- China Scholarship Council
Zitieren
APA
Xu, S., Jiemy, W. F., Boots, A. M. H., Arends, S., van Sleen, Y., Nienhuis, P. H., van der Geest, K. S. M., Heeringa, P., Brouwer, E., & Sandovici, M. (2024). Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis. Arthritis Care & Research. https://doi.org/10.1002/acr.25354
Vancouver
Xu S, Jiemy WF, Boots AMH, Arends S, van Sleen Y, Nienhuis PH, et al. Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis. Arthritis Care & Research. 2024. doi:10.1002/acr.25354
BibTeX
@article{Xu2024,
author = {Xu, Shuang and Jiemy, William F and Boots, Annemieke M H and Arends, Suzanne and van Sleen, Yannick and Nienhuis, Pieter H and van der Geest, Kornelis S M and Heeringa, Peter and Brouwer, Elisabeth and Sandovici, Maria},
title = {Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis},
journal = {Arthritis Care & Research},
year = {2024},
doi = {10.1002/acr.25354}
}
EUVIMED